Compare iShares MSCI Germany (DAX) (EWG) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Germany (DAX) vs Nomura Holdings Inc — how do they compare? iShares MSCI Germany (DAX) trades at $40.96 (market cap $1.42B), while Nomura Holdings Inc trades at $9.59 (market cap $27.55B). The key difference: Nomura Holdings Inc is far larger — about 19.4× iShares MSCI Germany (DAX)'s market cap, and Nomura Holdings Inc pays a 3.4% dividend while iShares MSCI Germany (DAX) pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Germany (DAX) for 54 Days and Nomura Holdings Inc for 55 Days on average.
| EWG | NMR | |
|---|---|---|
Market Cap | $1.42B | $27.55B |
Volume | 1,110,573 | 782,470 |
Sector | Broad Market / Factor | Financials |
52-Week High | $44.59 | $10.86 |
52-Week Low | $38.08 | $6.73 |
Typical Hold Time | 54 Days | 55 Days |
Enterprise Value | — | $38.54T |
Dividend Yield | — | 3.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWG is trading at $40.67, down 0.59% with a bearish technical outlook as moving averages and oscillators signal selling pressure. The stock faces resistance at $41 with support at $40. Recent European market news highlights ECB rate hikes and energy price concerns affecting regional equities, though some analysts note resilience in European stocks despite macroeconomic pressures.
The bearish technical indicators and European economic uncertainty create near-term headwinds. Investment opportunity exists if the stock holds above $40 support, but risks include further ECB tightening and energy-driven inflation. Upside potential requires breaking above $41 resistance with improved market sentiment toward European equities.
Nomura Holdings (NMR) trades at $9.54, up 0.1% on the day, with a bearish technical signal but strong fundamental metrics including a P/E of 11.33 and net income margin of 20.4%. Recent earnings show a mix of beats and misses, while cash flow trends indicate significant financing activity. The stock is near its support level of $9, with RSI indicators suggesting potential oversold conditions. Zacks Research highlighted NMR as a strong buy for momentum and value in September 2026, citing recent price strength.
The outlook for NMR is cautiously optimistic, supported by solid profitability and valuation, but tempered by bearish technicals and inconsistent earnings performance. Key risks include high debt levels and macroeconomic sensitivity, while analyst sentiment leans hold. Upside potential exists if earnings stabilize and technical support holds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Germany (DAX)
EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.
Read more on EWG →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
